BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morris G, Schorge S. Genetic therapies for neurological disease: state of the art and opportunities for next-generation approaches. Neuroscience 2022:S0306-4522(22)00126-9. [PMID: 35304290 DOI: 10.1016/j.neuroscience.2022.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Richardson A, Morris G. Rebuttal from Amy Richardson and Gareth Morris. J Physiol 2022. [PMID: 36149003 DOI: 10.1113/JP283577] [Reference Citation Analysis]
2 Richardson A, Morris G. Cross Talk opposing view: Animal models of epilepsy are more useful than human tissue-based approaches. J Physiol 2022. [PMID: 36148995 DOI: 10.1113/JP282186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rybarikova M, Almacellas Barbanoj A, Schorge S, Déglon N. CNS gene therapy: present developments and emerging trends accelerating industry-academia pathways. Hum Gene Ther 2022. [PMID: 36070435 DOI: 10.1089/hum.2022.177] [Reference Citation Analysis]
4 Duncan JS. Epilepsy in the 21st century. The Lancet Neurology 2022;21:501-3. [DOI: 10.1016/s1474-4422(22)00175-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]